Chris@NNW, Author at NetworkNewsWire

WednesdayOct 14, 2020 10:40 am

1933 Industries, Inc. (CSE: TGIF) (OTCQX: TGIFF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

1933 Industries, Inc. (CSE: TGIF) (OTCQX: TGIFF) is a vertically integrated growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of the value chain with cultivation, extraction, processing and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners. Having started life as the first Las Vegas-based cannabis cultivator servicing the medicinal market, 1933 Industries now boasts over 100 SKUs in their product portfolio along with 6 licensing partners. Paul Rosen, CEO of 1933 Industries, will be speaking…

WednesdayOct 14, 2020 10:35 am

4Front Ventures (CSE: FFNT) (OTCQX: FFNTF) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

4Front Ventures (CSE: FFNT) (OTCQX: FFNTF) owns, operates and manages cannabis cultivation and production facilities. 4Front operates one of the largest cannabis-product manufacturing sites in the world in the state of Washington, with two >50,000-square-foot indoor cultivation facilities yielding upwards of 400g/sq. ft. alongside additional cultivation facilities located in the states of Massachusetts and Illinois. 4Front has specialized in the production of premium-quality flower, edibles and oil-based products and has developed considerable expertise at scale with multiple extraction methodologies, including CO2 and volatile solvents. Separately, and in addition to its manufacturing business, 4Front also currently owns and manages medical dispensaries…

WednesdayOct 14, 2020 10:30 am

Schwazze (OTCQX: SHWZ) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

Schwazze (OTCQX: SHWZ), formerly knowns as Medicine Man Technologies, Inc., is creating a vertically-integrated platform in Colorado and beyond, which will comprised of a portfolio of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting and nutrients. Ultimately, the company intend to put together a series of businesses to create a premier cannabis-focused company consolidating the Colorado cannabis marketplace. Justin Dye, CEO & Chairman of Schwazze, will be delivering a keynote presentation alongside moderator Tony Noto, Cannabis Editor at Benzinga. To learn more about Schwazze, visit https://www.schwazze.com/ For registration information and further details on Benzinga’s Cannabis Capital Conference,…

WednesdayOct 14, 2020 10:25 am

GreenLane Holdings (NASDAQ: GNLN) Featured in Virtual Coverage of Benzinga’s Cannabis Capital Conference

GreenLane Holdings (NASDAQ: GNLN) is a holding company which, through its subsidiaries, supplies vaporization products and accessories to dispensaries and smoke shops across the United States and Canada. Since being founded in 2005, the company has grown to over 300 employees with operations in thirteen cities across North America and Europe, including seven highly automated distribution centers. Aaron LoCascio, CEO of GreenLane Holdings, and Bill Mote, CFO of GreenLane Holdings, will be participating in a forum entitled “High Tech: Technology Changing the Game for the Cannabis Consumer” together with Brian Cissell at 365 Cannabis and moderated by Michael Aiello of…

WednesdayOct 14, 2020 9:00 am

Multi-Billion-Dollar Market Forecast in Psychedelic Therapeutics

NetworkNewsWire Editorial Coverage: Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as "magic mushrooms." There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as…

TuesdayOct 13, 2020 2:01 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Takes Another Step Closer to Q1 Launch of Brain Cancer Drug Trial

CNS Pharmaceuticals is a pre-clinical-stage developer of novel brain cancer-fighting drugs, including its lead candidate Berubicin The company is working to build on promising results from a 2006 Phase I trial, which provided 44 percent of its limited patient pool with clinically significant improvement in disease stability and one patient with a durable complete response (no evidence of any tumor remaining) for over 14 years CNS Pharmaceuticals expects to launch a pivotal Phase II trial of Berubicin at the beginning of next year and has been assembling a team of partner companies help with the trial CNS recently announced that…

TuesdayOct 13, 2020 1:21 pm

Predictive Oncology Inc. (NASDAQ: POAI) CEO Schwartz Pens Letter to Shareholders, Elaborates on Ongoing Company Developments

Predictive Oncology’s CEO Carl Schwartz published open letter to company’s shareholders Schwartz elaborated on various developments within each of POAI’s divisions, has reiterated his optimism on company’s operations going forward CEO also revealed that company’s revenue trends have stabilized and are now on upward trend with cash burn beginning to decline Company also revealed its ability to access over $10 million in undrawn equity lines of credit Carl Schwartz, the CEO of Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, has recently published a…

TuesdayOct 13, 2020 12:52 pm

Kaival Brands Innovations Group Inc. (KAVL) Acquires Patent, Announces Lab, Enters Smoking Cessation Market

KAVL recently acquired patent, announced creation of wholly owned subsidiary to develop smoking cessation products. Company plans to create products that satisfy smokers but are free from nicotine’s addictive traits. CEO says company is excited to help “all nicotine users lead healthier and higher-quality lives.” The Centers for Disease Control and Prevention report that smoking is the leading cause of preventable death in the world today (https://nnw.fm/SajJo). With the help of new and innovative cessation products, the 7 million deaths that occur every year due to smoking could be prevented — and Kaival Brands Innovations Group (OTCQB: KAVL) is determined to do…

TuesdayOct 13, 2020 11:50 am

Sustainable Green Team Ltd. (SGTM) Expanding Operations Amid Global Recession

SGTM awarded contract for tree services in Lake County, Florida through subsidiary Central Florida Arborcare SGTM subsidiary Mulch Manufacturing recently awarded two additional packaging contracts Subsidiary ArborPro of Mississippi Inc. awarded contract for Hurricane Laura recovery efforts Q2 results include $12.3 million revenue and $3.4 million gross profit Sustainable Green Team (OTC: SGTM), a leading provider of environmentally-beneficial solutions for tree and storm waste disposal, recently announced that Central Florida Arborcare, its wholly-owned subsidiary, was awarded a one-year contract to supply tree trimming and related services to the county, renewable for an additional four times over a one-year period. Along…

TuesdayOct 13, 2020 9:00 am

Blockbuster Year and Bright Horizons for SPACs

NetworkNewsWire Editorial Coverage: The year 2020 has already seen 127 SPAC IPOs, which have collectively raised over $48.5 billion in proceeds — more than the past ten years combined. A special purpose acquisition company (SPAC) is essentially a blank-check company formed to raise capital through an IPO with the sole intent of buying or merging with another operating company. SPACs have evolved to become an expedited and cost-effective way of doing an M&A deal and have been utilized by multiple Wall Street heavyweights. Going public via a SPAC enables a company to get a deal done in weeks instead of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Author: Chris@NNW